|
|||||
|
|
The impact of human epidermal growth factor receptor 2 neoadjuvant monoclonal antibody (trastuzumab) therapy in ductal carcinoma in situ of the breast |
|
| Authors: | David M Parham Sarah E Pinder |
| Affiliation: | 1. Department of Pathology, Royal Bournemouth Hospital, Dorset, UK;2. Division of Cancer Studies, Kings College London, London, UK |
| Abstract: | |
| Keywords: | |